31 drugs will be included in medical insurance negotiation in Zhejiang Province

Source: great wisdom ashdak news agency on December 16, 2014, Zhejiang Provincial People's social security included 31 high-value drugs into the negotiation scope of special drugs for serious illness insurance in order to effectively solve the problem of special drugs for insured personnel suffering from serious and serious diseases At present, Zhejiang Province has started the work and invited the above-mentioned pharmaceutical manufacturers to negotiate The list is larger than the 15 drugs previously circulating The above 31 drugs (27 generic names) include imatinib mesylate, sunitinib malate, cetuximab, sorafenib mesylate, and recombinant human coagulation factor VIIa Among them, more than half are foreign-funded brands, including Novartis, Lilly, Pfizer, Bayer, etc.; domestic enterprises include Baitai pharmaceutical, CITIC Guojian, Jiangsu aosaikang, Zhengda Tianqing, Jiangsu Haosen pharmaceutical, etc See the attached table for details Zhejiang Province had an internal list out in November, when it said 15 drugs had been negotiated for coverage The final list of Zhejiang People's social insurance covers more varieties than before, and the negotiation object of varieties has been narrowed Taking pemetrexed disodium as an example, only two pharmaceutical companies, Jiangsu Haosen and Lily France, were invited to participate in the negotiation In the previous outflow list, 10 enterprises of this variety were shortlisted, including Qilu pharmaceutical, Jiangsu aosaikang, Zhendong Pharmaceutical (300158 SZ), etc The dashatini of Zhengda Tianqing defeated its competitor, Shiguibao, and won the final victory It is said that the drug price promotion of Zhengda Tianqing is one eighth of that of the original research In fact, it is common to introduce special drugs into medical insurance through negotiation mechanism Beijing, Qingdao, Jiangxi and other places have begun to introduce medical insurance negotiation mechanism Previously, officials from Jiangxi Provincial Department of human resources and Social Security introduced that the total price of five special drugs included in the scope of medical insurance in Jiangxi Province will be reduced to 159 million yuan through the start of negotiation mechanism, with a reduction rate of about 14.5% Attachment: